Gainers
- Concord Medical Services CCM shares moved upwards by 51.9% to $1.2 during Tuesday's regular session. The market value of their outstanding shares is at $52.1 million.
- Annexon ANNX shares increased by 32.96% to $6.09. The company's market cap stands at $562.7 million.
- Olema Pharmaceuticals OLMA stock moved upwards by 26.7% to $14.9. The company's market cap stands at $833.4 million.
- Pasithea Therapeutics KTTA shares moved upwards by 22.59% to $7.0. The market value of their outstanding shares is at $7.3 million.
- Fresh2 Group FRES stock moved upwards by 21.12% to $0.43. The company's market cap stands at $10.5 million.
- I-MAB IMAB stock rose 20.88% to $1.91. The company's market cap stands at $154.4 million.
Losers
- ENDRA Life Sciences NDRA shares decreased by 64.4% to $0.08 during Tuesday's regular session.
- Equillium EQ stock fell 22.45% to $1.14. The market value of their outstanding shares is at $40.1 million.
- Microbot Medical MBOT shares declined by 18.85% to $1.12. The market value of their outstanding shares is at $16.1 million.
- Inspire Veterinary IVP stock decreased by 18.36% to $2.58. The market value of their outstanding shares is at $2.5 million.
- Kintara Therapeutics KTRA shares fell 18.3% to $0.22. The market value of their outstanding shares is at $12.2 million.
- NewGenIvf Group NIVF stock fell 17.4% to $1.14. The company's market cap stands at $11.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ANNXAnnexon Inc
$2.71-0.73%
Edge Rankings
Momentum
9.30
Price Trend
Short
Medium
Long
CCMConcord Medical Services Holdings Ltd
$5.66-%
EQEquillium Inc
$0.33023.51%
IMABI-MAB
$2.205.26%
IVPInspire Veterinary Partners Inc
$1.373.01%
KTTAPasithea Therapeutics Corp
$0.7055-1.55%
MBOTMicrobot Medical Inc
$2.49-0.80%
NDRAENDRA Life Sciences Inc
$7.93129.4%
NIVFNewGenIvf Group Ltd
$0.6915-20.3%
OLMAOlema Pharmaceuticals inc
$4.634.04%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.